Abbott Laboratories Stock
Model's Crash-Guard Rule Active. Abbott Laboratories has declined more than 15% from its 60-day high while the signal score is very low (below 25). In this constellation, the calculation model suspends its cautious signal and flags a contrarian phase. The background is a backward-looking observation from backtests: comparable extreme constellations showed above-average recoveries in the past, that is neither a forecast nor a guarantee.
Findings
- The distance to the 52-week high is 19.7%.
- Strongest group: Momentum, 1 of 5 positive. Weakest: Trend, 0 of 5.
- The 30-day volatility of 21.1% sits in the lower third of the 416 titles in the universe.
Signal groups
Describes past price action, not a recommendation. As of October 26, 2026 at 08:03 AM, computed from the closing prices of the last trading day.
Key figures
- 1 day
- +1.2%
- 4 weeks
- +2.4%
- 52 weeks
- -18.0%
- Volatility 30 days
- 21.1%
- Max. decline 52 weeks
- -36.1%
- Distance to 52-week high
- -19.7%
- Sharpe ratio 1 year
- -0.81
In comparison
- The volatility sits in the lower third of the 44 titles in the Healthcare sector.
- The volatility sits in the lower third of the 133 titles on US exchanges.
The 16 signals
Each signal is one indicator. Tap it to see what it measures and what it currently shows for Abbott Laboratories.
EMA CrossoverCautious
For Abbott Laboratories, the fast moving average has crossed below the slow one. By this indicator's definition that corresponds to a downtrend, a description of past price action.
Compares a fast moving average to a slow one. When the fast is above the slow, the trend is positive. Period settings are automatically calibrated per asset class.
Read in the glossaryMA Trend Filter (200-day)Cautious
Checks whether the price is above or below its 200-day moving average, a look at the long-term trend.
ADX DirectionCautious
Shows whether upward or downward moves dominate in the trend whose strength the ADX measures (+DI versus -DI).
Read in the glossaryADX Trend Strength21.5Mixed
ADX stands at 21.5, a moderate trend.
ADX does not measure direction, only how pronounced a trend is, regardless of whether it points up or down. We use it as a filter: only above a certain value does a trend count as strong enough to give other signals more weight. Direction itself comes from the separate ADX Direction signal.
Read in the glossaryRegression Intercept1.02Cautious
Fits a straight line through the closing prices of a fixed window and compares its level today with its level a few days earlier. A rising line describes an uptrend.
RSI (14)54.0Mixed
RSI stands at 54.0, in the neutral zone between 45 and 55. Upward and downward moves over the last 14 trading days are roughly balanced.
The Relative Strength Index measures the ratio of upward to downward price movements over the last 14 trading days (Wilder smoothing) on a scale of 0 to 100. Our neutral zone is 45 to 55, tighter than the classic 30/70 band, outside of it the methodology reads the RSI as overbought or oversold.
Read in the glossaryMACD+0.3%Mixed
MACD stands at +0.3%, within the neutral zone around the threshold, no clear momentum in either direction.
MACD measures the gap between two exponentially smoothed averages. Our periods are 12/20/9 instead of the common 12/26/9, and the signal threshold is normalized to 0.3% of the current price rather than the raw MACD value, which keeps the threshold comparable across different price levels.
Read in the glossaryRate of Change-0.8%Cautious
Abbott Laboratories is -0.8% lower than 63 trading days ago, a negative medium-term price change.
Rate of Change measures the percentage price change over the last 63 trading days, roughly one quarter, a medium-term window, not a short-term daily or weekly read.
Read in the glossary52-Week High80.3%Mixed
Abbott Laboratories trades at 80.3% of its 52-week high, neither near the high nor far from it.
Measures how close the current price is to its highest point over the last 252 trading days, roughly one year. A value near 100% means the price is at or near its yearly high.
Read in the glossaryMomentum Oscillator+4.0%Positive
Abbott Laboratories shows an accelerating upward move at +4.0%, recent price gains are larger than before.
Checks whether the recent price movement is accelerating or decelerating. Unlike Rate of Change, this indicator measures the pace of the change, not the change itself.
Read in the glossaryWilliams %R-29.0Mixed
Williams %R stands at -29.0, a neutral position. The price is in the middle of the recent trading range, without extremes in either direction.
Williams %R shows where the current price sits within the high-low range of the last 14 trading days. We read it as contrarian: a favorable signal only fires on a confirmed turn upward out of the oversold zone, not on any low value by itself, an extreme oversold reading alone never produces a cautious signal for us.
Read in the glossaryStochastic %K71.0Mixed
Stochastic %K stands at 71.0, currently without a confirmed crossover in either direction.
The Stochastic oscillator shows where the closing price sits within the recent trading range. A low or high value alone isn't enough for us: a signal only fires once %K and %D are both below 20 (or above 80) and %K is crossing upward (or downward), a confirmed turning point rather than a raw level.
Read in the glossaryVIX Level19.4Mixed
The VIX derives the expected fluctuation of the next 30 days from options on the S&P 500. It describes the market environment and is the same for every title.
Read in the glossaryVIX Rate of Change-2.7%Mixed
Measures how much the VIX has changed over the last trading days. A fast rise stands for quickly growing expected fluctuation. The same for every title.
Read in the glossaryHY SpreadCautious
The yield premium of high-yield bonds over government bonds, a gauge of how the credit market prices default risk. It describes the market environment and is the same for every title.
Read in the glossaryRelative Strength0.96Cautious
Abbott Laboratories stands at 0.96, below the reference index, price performance over the period was weaker than the reference index's.
Compares price performance over a medium-term period against a broad stock market index as a reference. A value above 1.0 means stronger performance than the reference index, below 1.0 means weaker.
Analyze Abbott Laboratories in your own portfolio
edgio computes what you see here for Abbott Laboratories for every position in your portfolio, and gets in touch when something turns.
- Watch Abbott Laboratories: score and 16 signals on your watchlist, up to 5 titles
- Your own portfolio with up to 3 positions: score, risk and spread
- Weekly overview by email
- An email as soon as the score of Abbott Laboratories turns
- Signal history of Abbott Laboratories in hindsight
- Backtest: how the levels would have come through past crises with Abbott Laboratories
- Risk budget with a loss limit, up to 50 positions
7 days of Pro free, then Free automatically. No credit card.
How the score comes about
- 0116 signals per title
Trend, momentum, oscillators and the market environment (VIX, credit market), computed every trading day after the close from the closing prices.
- 02One score from 0 to 100
A weighted average, not a majority vote. From 70 Positive, 40 to 69 Mixed, below 40 Cautious.
- 03Tested in hindsight
The same methodology was tested in 12 time windows from 2014 to 2025, on 64 portfolios.
We do not publish the weighting of the individual signals. Methodology in detail
About Abbott Laboratories
Abbott Laboratories is a diversified global healthcare company that develops, manufactures, and markets medical devices, diagnostic systems, branded generic pharmaceuticals, and nutritional products. The Medical Devices segment is the largest and fastest-growing revenue driver, led by the FreeStyle Libre continuous glucose monitoring system and cardiovascular structural heart devices. The business is supported by global diagnostic instrumentation, clinical nutrition brands (Similac, Ensure), and established pharmaceutical products in emerging markets. Broad geographical reach across more than 160 countries and trusted medical brands provide defensive earnings stability. Founded in 1888 by Dr. Wallace C. Abbott, the company is headquartered in North Chicago, Illinois.
Technical reading
Technical analysis for Abbott Laboratories stock (NYSE: ABT), trend direction, momentum strength and risk metrics based on 16 quantitative signals, updated daily.
Trend. 0 of 5 trend signals read positive. ADX at 21.5 indicates a moderate trend. The price is below the 200-day moving average.
Momentum. 1 of 5 momentum signals read positive. RSI at 54.0 is in the neutral range.
Risk Metrics. 30-day volatility at 21.1%. price 20% below its 52-week high. Sharpe Ratio at -0.81 indicates a negative risk-adjusted return over 12 months.
Market Environment. VIX at 19.4 indicates normal expected market volatility. The high-yield spread signal reads cautious.
Sector Context. 52-week return of -18.0% is below the Healthcare sector average of 25.9%. Ranked #41 of 44 Healthcare titles by signal score.
Questions about Abbott Laboratories
How does Abbott Laboratories stand according to the edgio signals?
The signal score of Abbott Laboratories is 26 out of 100, which is the state Cautious. 1 of 16 signals are positive. As of October 26, 2026 at 08:03 AM.
What is the RSI of Abbott Laboratories?
The RSI (14) of Abbott Laboratories is 54.0. Upward and downward moves are roughly balanced. At edgio the neutral zone is 45 to 55.
Is this a forecast or a recommendation?
No. The signals describe past price action and the market environment. They do not predict the future and do not consider your personal situation. You make your own decisions.
How often is the score computed?
Every trading day after the close. The page shows the state of the latest computation.
In the Healthcare sector
Each cell is one title, sorted by signal score. Abbott Laboratories is highlighted.
Compare with another title
Two titles side by side, with the values of this page.
More Healthcare titles
Notes
The information presented does not constitute investment advice and should not be construed as a solicitation to buy or sell financial instruments. Past performance is not a reliable indicator of future results. Any investment decision should be based on your own research and, where appropriate, professional advice. Marvin Waraschitz, founder of edgio, currently holds no position in ABT.
The values are computed algorithmically from public market data (closing prices, VIX, credit spreads). Logos by Elbstream. Methodology & full disclaimer
Methodology & Background
- RSI Aktien: Was der Relative-Strength-Index misst, was er nicht misst und warum die Standardschwellen oft falsch eingesetzt werden (Deutsch) →
- EMA Crossover erklärt: Wie das Signal funktioniert und welche Perioden Tests bestanden haben (Deutsch) →
- 16 Signale, 148 Aktien, 12 Jahre: Was unsere Backtests wirklich zeigen (Deutsch) →